ACADIA Pharmaceuticals Inc
NASDAQ:ACAD

Watchlist Manager

ACADIA Pharmaceuticals Inc

NASDAQ:ACAD

Watchlist

Price: 16.42 USD 0.55% Market Closed

Market Cap: 2.7B USD

Have any thoughts about
ACADIA Pharmaceuticals Inc?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Walt Disney Co NYSE:DIS	Media
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 16.42 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

ACAD Alert

ACADIA Pharmaceuticals Inc

16.42

+0.09 (+0.55%)

52 Week Range	14.62 31.77
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	Abbvie Inc NYSE:ABBV	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Realty Income Corp NYSE:O	US
	Walt Disney Co NYSE:DIS	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

ACADIA Pharmaceuticals Inc

What unique competitive advantages
does ACADIA Pharmaceuticals Inc hold over its rivals?

What risks and challenges
does ACADIA Pharmaceuticals Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of ACADIA Pharmaceuticals Inc.

What unique competitive advantages
does ACADIA Pharmaceuticals Inc hold over its rivals?

What risks and challenges
does ACADIA Pharmaceuticals Inc face in the near future?

Has there been any significant insider trading activity
in ACADIA Pharmaceuticals Inc recently?

Summarize the latest earnings call
of ACADIA Pharmaceuticals Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for ACADIA Pharmaceuticals Inc.

Provide P/S
for ACADIA Pharmaceuticals Inc.

Provide P/E
for ACADIA Pharmaceuticals Inc.

Provide P/OCF
for ACADIA Pharmaceuticals Inc.

Provide P/FCFE
for ACADIA Pharmaceuticals Inc.

Provide P/B
for ACADIA Pharmaceuticals Inc.

Provide EV/S
for ACADIA Pharmaceuticals Inc.

Provide EV/GP
for ACADIA Pharmaceuticals Inc.

Provide EV/EBITDA
for ACADIA Pharmaceuticals Inc.

Provide EV/EBIT
for ACADIA Pharmaceuticals Inc.

Provide EV/OCF
for ACADIA Pharmaceuticals Inc.

Provide EV/FCFF
for ACADIA Pharmaceuticals Inc.

Provide EV/IC
for ACADIA Pharmaceuticals Inc.

Show me price targets
for ACADIA Pharmaceuticals Inc made by professional analysts.

What are the Revenue projections
for ACADIA Pharmaceuticals Inc?

How accurate were the past Revenue estimates
for ACADIA Pharmaceuticals Inc?

What are the Net Income projections
for ACADIA Pharmaceuticals Inc?

How accurate were the past Net Income estimates
for ACADIA Pharmaceuticals Inc?

What are the EPS projections
for ACADIA Pharmaceuticals Inc?

How accurate were the past EPS estimates
for ACADIA Pharmaceuticals Inc?

What are the EBIT projections
for ACADIA Pharmaceuticals Inc?

How accurate were the past EBIT estimates
for ACADIA Pharmaceuticals Inc?

Compare the revenue forecasts
for ACADIA Pharmaceuticals Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of ACADIA Pharmaceuticals Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of ACADIA Pharmaceuticals Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of ACADIA Pharmaceuticals Inc compared to its peers.

Compare the P/E ratios
of ACADIA Pharmaceuticals Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing ACADIA Pharmaceuticals Inc with its peers.

Analyze the financial leverage
of ACADIA Pharmaceuticals Inc compared to its main competitors.

Show all profitability ratios
for ACADIA Pharmaceuticals Inc.

Provide ROE
for ACADIA Pharmaceuticals Inc.

Provide ROA
for ACADIA Pharmaceuticals Inc.

Provide ROIC
for ACADIA Pharmaceuticals Inc.

Provide ROCE
for ACADIA Pharmaceuticals Inc.

Provide Gross Margin
for ACADIA Pharmaceuticals Inc.

Provide Operating Margin
for ACADIA Pharmaceuticals Inc.

Provide Net Margin
for ACADIA Pharmaceuticals Inc.

Provide FCF Margin
for ACADIA Pharmaceuticals Inc.

Show all solvency ratios
for ACADIA Pharmaceuticals Inc.

Provide D/E Ratio
for ACADIA Pharmaceuticals Inc.

Provide D/A Ratio
for ACADIA Pharmaceuticals Inc.

Provide Interest Coverage Ratio
for ACADIA Pharmaceuticals Inc.

Provide Altman Z-Score Ratio
for ACADIA Pharmaceuticals Inc.

Provide Quick Ratio
for ACADIA Pharmaceuticals Inc.

Provide Current Ratio
for ACADIA Pharmaceuticals Inc.

Provide Cash Ratio
for ACADIA Pharmaceuticals Inc.

What is the historical Revenue growth
over the last 5 years for ACADIA Pharmaceuticals Inc?

What is the historical Net Income growth
over the last 5 years for ACADIA Pharmaceuticals Inc?

What is the current Free Cash Flow
of ACADIA Pharmaceuticals Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for ACADIA Pharmaceuticals Inc.

ACAD

Income Statement

Income from Continuing Operations

ACADIA Pharmaceuticals Inc
Income from Continuing Operations

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

ACADIA Pharmaceuticals Inc
Income from Continuing Operations Peer Comparison

Comparables:

ABBV

GILD

AMGN

VRTX

REGN

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

	Income from Continuing Operations	CAGR 3Y	CAGR 5Y	CAGR 10Y
ACADIA Pharmaceuticals Inc NASDAQ:ACAD	Income from Continuing Operations $30.5m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
Abbvie Inc NYSE:ABBV	Income from Continuing Operations $5.4B	CAGR 3-Years -7%	CAGR 5-Years 5%	CAGR 10-Years 3%
Gilead Sciences Inc NASDAQ:GILD	Income from Continuing Operations $1B	CAGR 3-Years -41%	CAGR 5-Years -30%	CAGR 10-Years -18%
Amgen Inc NASDAQ:AMGN	Income from Continuing Operations $3.1B	CAGR 3-Years -18%	CAGR 5-Years -17%	CAGR 10-Years -5%
Vertex Pharmaceuticals Inc NASDAQ:VRTX	Income from Continuing Operations -$489.9m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years 1%
Regeneron Pharmaceuticals Inc NASDAQ:REGN	Income from Continuing Operations $4.3B	CAGR 3-Years -11%	CAGR 5-Years 17%	CAGR 10-Years 27%

What is ACADIA Pharmaceuticals Inc's Income from Continuing Operations?

Income from Continuing Operations
30.5m USD

Based on the financial report for Jun 30, 2024, ACADIA Pharmaceuticals Inc's Income from Continuing Operations amounts to 30.5m USD.

ACADIA Pharmaceuticals Inc
NASDAQ:ACAD

ACADIA Pharmaceuticals Inc
Income from Continuing Operations

ACADIA Pharmaceuticals Inc
Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

See Also

What is ACADIA Pharmaceuticals Inc's Income from Continuing Operations?

Income from Continuing Operations
30.5m USD

Company

Help

Tools

Stocks

ACADIA Pharmaceuticals Inc NASDAQ:ACAD

ACADIA Pharmaceuticals Inc Income from Continuing Operations

ACADIA Pharmaceuticals Inc Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis Latest Figures & CAGR of Competitors

See Also

What is ACADIA Pharmaceuticals Inc's Income from Continuing Operations? Income from Continuing Operations 30.5m USD

Company

Help

Tools

Stocks

ACADIA Pharmaceuticals Inc
NASDAQ:ACAD

ACADIA Pharmaceuticals Inc
Income from Continuing Operations

ACADIA Pharmaceuticals Inc
Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

What is ACADIA Pharmaceuticals Inc's Income from Continuing Operations?

Income from Continuing Operations
30.5m USD